Blocknomi
Key Takeaways Shares of Capricor Therapeutics plummeted up to 70% following critical FDA staff commentary on deramiocel Federal regulators highlighted that the company modified outcome measurements post-trial completion FDA staff…
Related articles
-
Micron (MU) Stock Climbs 3% Despite CXMT’s Explosive IPO Debut in China
Blocknomi Published 27.07.2026 10:35
-
Bitcoin And Ethereum ETF Inflows Return As Institutions Step Back Into Crypto Funds
NewsBTC Published 13.07.2026 12:50
-
Crypto ‘wrench attacks’ persist as total climbs to 52 and value targeted jumps more than tenfold, CertiK says
The Block Published 22.07.2026 15:48
-
Bitcoin is trading through a dangerous weekend as 20% of the world’s oil hangs in the balance
CryptoSlate Published 18.07.2026 17:00
-
Apple Stock Forecast Rises, but Can AAPL Reach $330?
Blocknomi Published 24.07.2026 13:49
-
Stablecoin Sportsbooks Versus Traditional Payments
Crypto Daily Published 14.07.2026 07:38
-
Ethereum Price Analysis: ETH Hits a Decision Point as Major Resistance Comes Into Play
CryptoPotato Published 26.07.2026 13:22
-
BloFin Wallet Unifies Visa Payments and Perpetual Trading for the Next Era of Finance
Bitcoin.com Published 25.07.2026 12:23